The ongoing epidemic requires an adequate response. In terms of the upcoming weeks, Slovakia should proceed in an organized and responsible manner.
The epidemic of good advice, tips, challenges, and recommendations for the new Slovak government is much stronger than the viral one. There are many things to fix, to improve, and especially – to save.
The eagerly awaited parliamentary elections in Slovakia are all over. Igor Matovič, the expected new Slovakian Prime Minister, became the clear winner with his anti-corruption movement “Ordinary People and Independent Personalities” (OĽaNO).
Igor Matovič, the leader of OĽANO, had been appointed to establish a new governing coalition and the talks between parties that passed the threshold started. SMER-SD and ĽSNS will be in the opposition, while Matovič is negotiating with Sme-rodina, Za ľudí, and SaS.
With the parliamentary elections approaching, Slovakia is facing an unprecedented situation of uncertainty. The elections are held after four challenging years, marked by the murder of the journalist Ján Kuciak and his fiancée Martina Kušnírová, and number of subsequent anti-government protests.
The current Vice-President of the European Commission Mr. Timmermans openly says that a minimum wage of 60% of the median wage should be paid in the EU. In addition, the European Commission launched consultations with trade unions and employers on EU minimum wage rules in January.
The Visegrád Cooperation is not nearly as united and indissoluble as the Hungarian Government wishes to present it. Member states often have conflicting interests which are pursued to the detriment of each other and cooperation.
The Liberals are looking to the next parliamentary elections in Slovakia with hope, but also with concern. This is pretty much picture of the mood in the country at the moment. The elections to the Slovak National Council, a unicameral parliament with 150 MPs, will take place on February 29, 2020.
Slovak public has recently experienced number of front-page stories about patients, who were refused payment for innovative highly expensive drugs by health insurance companies. Stories, which attracted a lot of emotions and stirred the public and which are vanguard of much bigger future troubles in public healthcare.